x

Search for a clinical trial

* (*) mandatory field

A Randomized, Multicenter, Phase III Trial of Trabectedin (Yondelis®) versus Doxorubicin-based Chemotherapy as First-Line Therapy in Patients with Translocation-Related Sarcomas (TRS) - UK

  • Type of clinical trial : Protocol clinical trial
  • Recruiting project : -
  • Status : Ongoing trial
  • Funding body(ies) :
  • Geographic coverage : Global
  • Sponsor : Johnson & johnson pharmaceutical research & development, llc.
  • Website
    • Phase : III
  • Principal investigator of clinical trial

  • INFORMATION NOT PROVIDED
  • Institution: Information not provided - UK
  • ADDRESS: NOT PROVIDED - UK NYI UK
  • UNITED KINGDOM
  • More information
  • Phone  : -
  • Fax  : -
Last update: May 2014

Additional information

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.